[Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors]
Related Experiment Video
Updated: Aug 9, 2025

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
Gang Xie1, Jing Cheng1, Junping Zhang1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.
Abstract:
Chemokine-like factor-like MARVEL transmembrane domain containing member/chemokine-like factor superfamily member (CMTM/CKLFSF) including CKLF and CMTM1-CMTM8 are a new family of proteins linking chemokines and transmembrane superfamilies. CMTM not only have broad chemotactic activities, but also associate with hematopoietic system, immune system, and tumor development and metastasis closely. CMTM proteins are involved in key biological processes of cancer development, which include activation and recycling of growth factor receptors, cell proliferation and metastasis, and regulation of the tumor immune microenvironment. This is a new focus of research on the relationship between CMTM and tumors, because CMTM4/CMTM6 can be considered as a regulator for programmed cell death ligand 1 (PD-L1). This paper reviews the role of CMTM family members on cancer, especially in tumor growth, metastasis and immune escape, summarize the latest findings on the relationship between CMTM and non-small cell lung cancer, and explores the potential clinical value of CMTM as a novel drug target or biomarker. .
Insights
Chemokine-like factor-like MARVEL transmembrane domain containing member (CMTM) proteins are implicated in cancer development, growth, and immune evasion. CMTM4/CMTM6 regulate PD-L1, highlighting their potential as cancer drug targets.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Chemokine-like factor-like MARVEL transmembrane domain containing member (CMTM/CKLFSF) proteins link chemokines and transmembrane superfamilies.
- CMTMs exhibit broad chemotactic activities and are closely associated with the hematopoietic and immune systems, as well as tumor development and metastasis.
Approach:
- This review synthesizes current research on the role of CMTM family members in cancer.
- It specifically examines their involvement in tumor growth, metastasis, and immune escape.
- The paper highlights recent findings concerning CMTM and non-small cell lung cancer.
Key Points:
- CMTM proteins are integral to key cancer development processes, including growth factor receptor regulation, cell proliferation, metastasis, and tumor immune microenvironment modulation.
- CMTM4 and CMTM6 are identified as regulators of programmed cell death ligand 1 (PD-L1), a critical factor in tumor immune evasion.
- The study emphasizes the emerging understanding of CMTM's role in cancer biology.
Conclusions:
- CMTM family members play a significant role in various aspects of cancer progression and immune response.
- CMTMs represent a promising area for novel cancer therapeutic strategies and biomarker development.
- Further research into CMTM's clinical value, particularly in non-small cell lung cancer, is warranted.
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
Chemotaxis and Direction of Cell Migration
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Differentiation of Common Myeloid Progenitor Cells

